Step 1: Understanding pFox inhibitors. Partial Fatty acid oxidation (pFox) inhibitors, such as Trimetazidine, work by shifting myocardial energy metabolism from fatty acid oxidation to glucose oxidation. This is more oxygen-efficient and helps improve cardiac efficiency, especially in conditions like ischemic heart disease.
Step 2: Explanation of Trimetazidine. Trimetazidine is the prototype pFox inhibitor. It selectively inhibits long-chain 3-ketoacyl-CoA thiolase (an enzyme involved in fatty acid oxidation), thereby enhancing glucose oxidation and reducing myocardial oxygen demand.
Step 3: Comparison with other options. - Option \( (B) \): Atosiban is an oxytocin receptor antagonist used in preterm labor, not a pFox inhibitor.
- Option \( (C) \): Verapamil is a calcium channel blocker used for angina and arrhythmias, not a pFox inhibitor.
- Option \( (D) \): Nicardipine is also a calcium channel blocker and not related to fatty acid oxidation.
Conclusion: Trimetazidine is the correct answer as a pFox inhibitor.
This question asks which drug acts as a partial fatty acid oxidation (pFox) inhibitor, a class of anti-anginal drugs that work by changing which fuel the heart muscle burns. A good way to answer is to sort each drug by its known pharmacological class and check whether that class fits the pFox mechanism.
Only one of the four drugs actually changes the heart's fuel preference from fat to glucose, which is the defining feature of a pFox inhibitor.
Therefore, the correct answer is Trimetazidine.
List I | List II | ||
|---|---|---|---|
| A | \(\Omega^{-1}\) | I | Specific conductance |
| B | \(∧\) | II | Electrical conductance |
| C | k | III | Specific resistance |
| D | \(\rho\) | IV | Equivalent conductance |
List I | List II | ||
|---|---|---|---|
| A | Constant heat (q = 0) | I | Isothermal |
| B | Reversible process at constant temperature (dT = 0) | II | Isometric |
| C | Constant volume (dV = 0) | III | Adiabatic |
| D | Constant pressure (dP = 0) | IV | Isobar |